Kinga K Tomczak MD PhD
Director, Tic Disorders and Tourette Syndrome Program, Boston Children's Hospital
Join to view full profile
300 Longwood AveBoston, MA 02115
Phone+1 781-216-2525
Fax+1 781-216-2517
Dr. Tomczak is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Harvard T.H. Chan School of Public HealthProgram in Clinical Effectiveness, 2022 - 2022
Boston University Medical CenterFellowship, Child Neurology, 2010 - 2013
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2007 - 2010
University of Medical Science PoznanClass of 2000
Certifications & Licensure
MA State Medical License 2012 - 2027
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Tourette Syndrome Behavior Therapy Institute (TS-BTI) Comprehensive Behavioral Intervention for Tics Certification
Clinical Trials
- Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults Start of enrollment: 2023 Jan 31
Roles: Contact
- A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder Start of enrollment: 2023 Aug 16
Roles: Contact
Publications & Presentations
PubMed
- 3 citationsEfficacy and Safety of Ecopipam for Tourette Syndrome: A Phase 3 Randomized Clinical Trial.Donald L Gilbert, Sarah D Atkinson, David J B Kim, Meredith M Miller, Patricia M Rice
JAMA Neurology. 2026-07-01 - 1 citationsComplementary and Integrative Medicine for the Treatment of Tourette's Syndrome.Tamara Pringsheim, Catherine Deans, Saar Anis, Poonam Bhatia, Kevin Black
Movement Disorders Clinical Practice. 2026-05-01 - Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators.Kinga K Tomczak, Jason P Swindle, Firas M Dabbous, Donald L Gilbert, George B Karkanias
Frontiers in Psychiatry. 2026-01-01
Journal Articles
- Subjective impact of COVID-19 pandemic on youth with tic and OCD spectrum disorders.Tomczak KK, Worhach J, Thuy Trang Nguyen S, Liu S, Hoeppner S, Zhang B, Greenberg E., Personalized Medicine in Psychiatry, 4/10/2023
Press Mentions
Novel Drug for Tourette Syndrome Safe, Effective for Kids and AdultsOctober 13th, 2025
Committees
- Co-Chair of Diversity Subcommittee, Joint Committee for Status of Women at Harvard Medical School and Harvard School of Dental Medicine
External Links
- Tic Disorders and Tourette Syndrome Programhttps://www.childrenshospital.org/programs/tic-disorders-and-tourette-syndrome-program
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: